BMJ

FacebookTwitter
Professional/CME

http://heart.bmj.com/content/94/6/706.full The abstract/extract view of this article is free (link available in right hand box). Access to the full text of this article requires a subscription or payment. To view this item, select one of the options below: or

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels -- Hausenloy and Yellon 94 (6): 706 -- Heart

The abstract/extract view of this article is free (link available in right hand box). Access to the full text of this article requires a subscription or payment. To view this item, select one of the options below: or Pay per Article - You may access this article (from the computer you are currently using) for 1 day.

Management of dyslipidaemias -- Paramsothy and Knopp 92 (10): 1529 -- Heart

http://heart.bmj.com/content/92/10/1529.full

Peri-articular ‘hard tumours’ in soft tissues -- Varma et al. 75 (886): 492 -- Postgraduate Medical Journal

http://pmj.bmj.com/content/75/886/492.full A 17-year-old man presented with painless, progressively increasing, non-simultaneous, peri-articular swellings evolving for the last 7 years. He had undergone repeated drainage of white chalky material and received adequate antitubercular therapy without any relief. He subsequently developed multiple non-healing sinuses. There was no history of colicky pain, graveluria, dyspnoea, excessive intake of antacids and vitamin D preparations, trauma or family history of similar disorder.
The abstract/extract view of this article is free (link available in right hand box). Access to the full text of this article requires a subscription or payment. To view this item, select one of the options below: or Pay per Article - You may access this article (from the computer you are currently using) for 1 day.

Review: once daily LMWH is as effective as twice daily LMWH for initial treatment of venous thromboembolism -- 9 (2): 51 -- Evidence-Based Nursing

http://ebn.bmj.com/content/9/2/51.full
http://ebm.bmj.com/content/6/6/188.full QUESTION: In patients with suspected venous thromboembolism (VTE) (ie, deep venous thrombosis [DVT] or pulmonary embolism [PE]), can a quantitative latex d -dimer assay rule out VTE? Design Blinded comparison of the results of the latex d -dimer test (MDA d -Dimer, Organon Teknika Corporation, Durham, NC, USA) with objective testing done at presentation and during follow up (3 mo). Setting 4 tertiary care university medical centres in Ontario, Canada. Patients

A negative quantitative latex d-dimer assay helped to rule out venous thromboembolism -- 6 (6): 188 -- Evidence-Based Medicine

http://emj.bmj.com/content/24/7/495.full

Prophylaxis of venous thromboembolism in patients with lower limb plaster cast immobilisation -- Brown and Bleetman 24 (7): 495 -- Emergency Medicine Journal

The abstract/extract view of this article is free (link available in right hand box). Access to the full text of this article requires a subscription or payment. To view this item, select one of the options below:
The renal tubule is responsible for the reabsorption of more than 99% of the water and sodium in the glomerular ultrafiltrate. Congenital or acquired tubular dysfunction can therefore readily cause profound electrolyte and volume disturbance. The tubule also has to regulate acid–base balance, mineral homoeostasis, and the excretion of organic anions and drugs. http://adc.bmj.com/content/83/3/189.full

Molecular developments in renal tubulopathies -- VAN'T HOFF 83 (3): 189 -- Archives of Disease in Childhood

The abstract/extract view of this article is free (link available in right hand box). Access to the full text of this article requires a subscription or payment. To view this item, select one of the options below: or Pay per Article - You may access this article (from the computer you are currently using) for 1 day.

Peripheral blood culture contamination in adults and venepuncture technique: prospective cohort study -- Qamruddin et al. 61 (4): 509 -- Journal of Clinical Pathology

http://jcp.bmj.com/content/61/4/509.full
The abstract/extract view of this article is free (link available in right hand box). Access to the full text of this article requires a subscription or payment. To view this item, select one of the options below: or Pay per Article - You may access this article (from the computer you are currently using) for 1 day. Regain Access to an already purchased article if the access period has not yet expired.

Is it my calcium, Doctor? -- Stanley and Shaw 94 (6): 169 -- ADC - Education and Practice

http://ep.bmj.com/content/94/6/169.full

Acute glomerulonephritis -- Vinen and Oliveira 79 (930): 206 -- Postgraduate Medical Journal

+ Author Affiliations Correspondence to: Professor David Oliveira, Department of Renal Medicine, St George’s Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK; d.oliveira@sghms.ac.uk Received 17 May 2002 Accepted 5 November 2002 Abstract Glomerulonephritis is an important cause of renal failure thought to be caused by autoimmune damage to the kidney. While each type of glomerulonephritis begins with a unique initiating stimulus, subsequent common inflammatory and fibrotic events lead to a final pathway of progressive renal damage. http://pmj.bmj.com/content/79/930/206.full

Alveolar haemorrhage in anti-glomerular basement membrane disease without detectable antibodies by conventional assays -- Serisier et al. 61 (7): 636 -- Thorax

+ Author Affiliations Correspondence to: Dr D J Serisier Department of Respiratory Medicine, Mater Adult Hospital, Raymond Tce, South Brisbane, Queensland 4101, Australia; david_serisier@mater.org.au Received 21 May 2004 Accepted 8 October 2004 Abstract Anti-glomerular basement membrane (anti-GBM) disease represents the spectrum of disease attributable to circulating anti-GBM antibodies.

Reduced mucosal antimicrobial activity in Crohn’s disease of the colon -- Nuding et al. 56 (9): 1240 -- Gut

The abstract/extract view of this article is free (link available in right hand box). Access to the full text of this article requires a subscription or payment. To view this item, select one of the options below:

Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab) -- Arzoo et al. 61 (10): 922 -- Annals of the Rheumatic Diseases

+ Author Affiliations Correspondence to: Dr H A Liebman, Division of Hematology, Kenneth Norris Jr Cancer Center, MS 34, 1441 Eastlake Ave, Los Angeles, CA 90033, USA; liebman@hsc.usc.edu Accepted 12 February 2002 Abstract Background: Rituximab, a chimeric monoclonal anti-CD20 antibody, has recently been used for the treatment of refractory antibody mediated autoimmune diseases such as immune mediated thrombocytopenia and haemolytic anaemia. Patients: Because of its novel mechanism of action, rituximab was used to treat three patients with refractory systemic antibody mediated autoimmune disorders. The first patient, a 71 year old woman with idiopathic type II mixed essential cryoglobulinaemia, had both dermatological and neurological manifestations with marked renal disease attributed to her cryoglobulinaemia.